BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7715294)

  • 1. Safety and activity of saquinavir in HIV infection.
    Kitchen VS; Skinner C; Ariyoshi K; Lane EA; Duncan IB; Burckhardt J; Burger HU; Bragman K; Pinching AJ; Weber JN
    Lancet; 1995 Apr; 345(8955):952-5. PubMed ID: 7715294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.
    Schapiro JM; Winters MA; Stewart F; Efron B; Norris J; Kozal MJ; Merigan TC
    Ann Intern Med; 1996 Jun; 124(12):1039-50. PubMed ID: 8633817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group.
    Collier AC; Coombs RW; Schoenfeld DA; Bassett RL; Timpone J; Baruch A; Jones M; Facey K; Whitacre C; McAuliffe VJ; Friedman HM; Merigan TC; Reichman RC; Hooper C; Corey L
    N Engl J Med; 1996 Apr; 334(16):1011-7. PubMed ID: 8598838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity.
    Vella S; Galluzzo C; Giannini G; Pirillo MF; Duncan I; Jacobsen H; Andreoni M; Sarmati L; Ercoli L
    Antiviral Res; 1996 Jan; 29(1):91-3. PubMed ID: 8721555
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection.
    Vella S; Lazzarin A; Carosi G; Sinicco A; Armignacco O; Angarano G; Andreoni M; Tambussi G; Chiodera A; Floridia M; Scaccabarozzi S; Facey K; Duncan I; Boudes P; Bragman K
    Antivir Ther; 1996 Aug; 1(3):129-40. PubMed ID: 11322246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV therapy advances. Update on a proteinase inhibitor.
    Vella S
    AIDS; 1994 Sep; 8 Suppl 3():S25-9. PubMed ID: 7840913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No tease this time--pros and cons of a long-awaited anti-HIV drug.
    Chang HE
    Posit Aware; 1996; 7(1):18-20. PubMed ID: 11363118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with saquinavir.
    Vella S
    AIDS; 1995 Dec; 9 Suppl 2():S21-S25. PubMed ID: 8775803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with zidovudine, didanosine and saquinavir.
    Collier AC; Coombs RW; Schoenfeld DA; Bassett R; Baruch A; Corey L
    Antiviral Res; 1996 Jan; 29(1):99. PubMed ID: 8721557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stanford study of saquinavir reveals low toxicities.
    AIDS Patient Care; 1995 Dec; 9(6):304-5. PubMed ID: 11361442
    [No Abstract]   [Full Text] [Related]  

  • 11. Saquinavir (Roche protease inhibitor) at higher doses.
    AIDS Treat News; 1995 Sep; (no 231):5. PubMed ID: 11362870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saquinavir (Invirase).
    Treat Rev; 1996 Apr; (no 21):5. PubMed ID: 11363396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New saquinavir formulation enters clinical trials.
    Torres G
    GMHC Treat Issues; 1996 Jan; 10(1):7-8. PubMed ID: 11363375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saquinavir: an HIV proteinase inhibitor.
    Bragman K
    Adv Exp Med Biol; 1996; 394():305-17. PubMed ID: 8815695
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on HIV protease inhibitors.
    Vella S
    AIDS Clin Care; 1995 Oct; 7(10):79-82, 88. PubMed ID: 11362832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boston, Galveston, Jackson County, Jefferson County, New York City, Portland--new saquinavir trial.
    AIDS Treat News; 1995 Sep; (no 231):6. PubMed ID: 11362872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ritonavir plus saquinavir: two trials with different results.
    Mascolini M
    AIDS Treat News; 1996 Sep; (No 254):5-6. PubMed ID: 11363819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saquinavir prolongs survival and slows disease progression.
    BETA; 1996 Jun; ():6. PubMed ID: 11363649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conference highlight.
    J Int Assoc Physicians AIDS Care; 1995 Aug; 1(7):26. PubMed ID: 11362749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European hurdles for saquinavir.
    J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):44. PubMed ID: 11363099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.